Literature DB >> 29364506

The mitochondrial transcription factor TFAM in neurodegeneration: emerging evidence and mechanisms.

Inhae Kang1,2, Charleen T Chu3, Brett A Kaufman2.   

Abstract

The mitochondrial transcription factor A, or TFAM, is a mitochondrial DNA (mtDNA)-binding protein essential for genome maintenance. TFAM functions in determining the abundance of the mitochondrial genome by regulating packaging, stability, and replication. More recently, TFAM has been shown to play a central role in the mtDNA stress-mediated inflammatory response. Emerging evidence indicates that decreased mtDNA copy number is associated with several aging-related pathologies; however, little is known about the association of TFAM abundance and disease. In this Review, we evaluate the potential associations of altered TFAM levels or mtDNA copy number with neurodegeneration. We also describe potential mechanisms by which mtDNA replication, transcription initiation, and TFAM-mediated endogenous danger signals may impact mitochondrial homeostasis in Alzheimer, Huntington, Parkinson, and other neurodegenerative diseases.
© 2018 Federation of European Biochemical Societies.

Entities:  

Keywords:  zzm321990TFAMzzm321990; mitochondrial DNA; neurodegeneration

Mesh:

Substances:

Year:  2018        PMID: 29364506      PMCID: PMC5851836          DOI: 10.1002/1873-3468.12989

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  137 in total

1.  Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons.

Authors:  Mats I Ekstrand; Mügen Terzioglu; Dagmar Galter; Shunwei Zhu; Christoph Hofstetter; Eva Lindqvist; Sebastian Thams; Anita Bergstrand; Fredrik Sterky Hansson; Aleksandra Trifunovic; Barry Hoffer; Staffan Cullheim; Abdul H Mohammed; Lars Olson; Nils-Göran Larsson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

2.  Regional variation in mitochondrial DNA copy number in mouse brain.

Authors:  Satoshi Fuke; Mie Kubota-Sakashita; Takaoki Kasahara; Yasufumi Shigeyoshi; Tadafumi Kato
Journal:  Biochim Biophys Acta       Date:  2010-12-08

3.  Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease.

Authors:  V M Mann; J M Cooper; D Krige; S E Daniel; A H Schapira; C D Marsden
Journal:  Brain       Date:  1992-04       Impact factor: 13.501

4.  MitoPark mice mirror the slow progression of key symptoms and L-DOPA response in Parkinson's disease.

Authors:  D Galter; K Pernold; T Yoshitake; E Lindqvist; B Hoffer; J Kehr; N-G Larsson; L Olson
Journal:  Genes Brain Behav       Date:  2009-10-07       Impact factor: 3.449

5.  Localization of phosphorylated ERK/MAP kinases to mitochondria and autophagosomes in Lewy body diseases.

Authors:  Jian-Hui Zhu; Fengli Guo; John Shelburne; Simon Watkins; Charleen T Chu
Journal:  Brain Pathol       Date:  2003-10       Impact factor: 6.508

6.  Reduced mitochondrial DNA transcription in senescent rat heart.

Authors:  A L Andreu; M A Arbos; A Perez-Martos; M J Lopez-Perez; J Asin; N Lopez; J Montoya; S Schwartz
Journal:  Biochem Biophys Res Commun       Date:  1998-11-27       Impact factor: 3.575

7.  Mitochondrial DNA damage is a hallmark of chemically induced and the R6/2 transgenic model of Huntington's disease.

Authors:  Karina Acevedo-Torres; Lexsy Berríos; Nydia Rosario; Vanessa Dufault; Serguei Skatchkov; Misty J Eaton; Carlos A Torres-Ramos; Sylvette Ayala-Torres
Journal:  DNA Repair (Amst)       Date:  2008-11-20

8.  A novel intermediate in transcription initiation by human mitochondrial RNA polymerase.

Authors:  Yaroslav I Morozov; Karen Agaronyan; Alan C M Cheung; Michael Anikin; Patrick Cramer; Dmitry Temiakov
Journal:  Nucleic Acids Res       Date:  2014-01-06       Impact factor: 16.971

Review 9.  APP mouse models for Alzheimer's disease preclinical studies.

Authors:  Hiroki Sasaguri; Per Nilsson; Shoko Hashimoto; Kenichi Nagata; Takashi Saito; Bart De Strooper; John Hardy; Robert Vassar; Bengt Winblad; Takaomi C Saido
Journal:  EMBO J       Date:  2017-08-01       Impact factor: 11.598

10.  Mitochondrial DNA Depletion in Respiratory Chain-Deficient Parkinson Disease Neurons.

Authors:  Anne Grünewald; Karolina A Rygiel; Philippa D Hepplewhite; Christopher M Morris; Martin Picard; Doug M Turnbull
Journal:  Ann Neurol       Date:  2016-01-28       Impact factor: 10.422

View more
  61 in total

1.  Drosophila MICOS knockdown impairs mitochondrial structure and function and promotes mitophagy in muscle tissue.

Authors:  Li-Jie Wang; Tian Hsu; Hsiang-Ling Lin; Chi-Yu Fu
Journal:  Biol Open       Date:  2020-12-02       Impact factor: 2.422

2.  White Matter Abnormalities Linked to Interferon, Stress Response, and Energy Metabolism Gene Expression Changes in Older HIV-Positive Patients on Antiretroviral Therapy.

Authors:  Isaac H Solomon; Sukrutha Chettimada; Vikas Misra; David R Lorenz; Robert J Gorelick; Benjamin B Gelman; Susan Morgello; Dana Gabuzda
Journal:  Mol Neurobiol       Date:  2019-11-05       Impact factor: 5.590

Review 3.  Role of mitochondria in diabetic peripheral neuropathy: Influencing the NAD+-dependent SIRT1-PGC-1α-TFAM pathway.

Authors:  Krish Chandrasekaran; Muragundla Anjaneyulu; Joungil Choi; Pranith Kumar; Mohammad Salimian; Cheng-Ying Ho; James W Russell
Journal:  Int Rev Neurobiol       Date:  2019-06-08       Impact factor: 3.230

Review 4.  Parkinson's disease, aging and adult neurogenesis: Wnt/β-catenin signalling as the key to unlock the mystery of endogenous brain repair.

Authors:  Bianca Marchetti; Cataldo Tirolo; Francesca L'Episcopo; Salvatore Caniglia; Nunzio Testa; Jayden A Smith; Stefano Pluchino; Maria F Serapide
Journal:  Aging Cell       Date:  2020-02-12       Impact factor: 9.304

5.  Phoenixin 20 promotes neuronal mitochondrial biogenesis via CREB-PGC-1α pathway.

Authors:  Yanwen Yang; Yinglian Lv; Junpeng Liu; Shuyun Zhang; Yun Li; Yong Shi
Journal:  J Mol Histol       Date:  2020-03-31       Impact factor: 2.611

Review 6.  An inducible MAO-B mouse model of Parkinson's disease: a tool towards better understanding basic disease mechanisms and developing novel therapeutics.

Authors:  Manish Chamoli; Shankar J Chinta; Julie K Andersen
Journal:  J Neural Transm (Vienna)       Date:  2018-04-30       Impact factor: 3.575

Review 7.  The mitochondrial biogenesis signaling pathway is a potential therapeutic target for myasthenia gravis via energy metabolism (Review).

Authors:  Lingling Ke; Qing Li; Jingwei Song; Wei Jiao; Aidong Ji; Tongkai Chen; Huafeng Pan; Yafang Song
Journal:  Exp Ther Med       Date:  2021-05-02       Impact factor: 2.447

8.  Kidney epithelial targeted mitochondrial transcription factor A deficiency results in progressive mitochondrial depletion associated with severe cystic disease.

Authors:  Ken Ishii; Hanako Kobayashi; Kensei Taguchi; Nan Guan; Andraia Li; Carmen Tong; Olena Davidoff; Pamela V Tran; Madhulika Sharma; Navdeep S Chandel; Meghan E Kapp; Agnes B Fogo; Craig R Brooks; Volker H Haase
Journal:  Kidney Int       Date:  2020-11-04       Impact factor: 10.612

9.  Pyrroloquinoline quinone promotes mitochondrial biogenesis in rotenone-induced Parkinson's disease model via AMPK activation.

Authors:  Qiong Cheng; Juan Chen; Hui Guo; Jin-Li Lu; Jing Zhou; Xin-Yu Guo; Yue Shi; Yu Zhang; Shu Yu; Qi Zhang; Fei Ding
Journal:  Acta Pharmacol Sin       Date:  2020-08-28       Impact factor: 6.150

10.  ATF4 activation promotes hepatic mitochondrial dysfunction by repressing NRF1-TFAM signalling in alcoholic steatohepatitis.

Authors:  Liuyi Hao; Wei Zhong; Haibo Dong; Wei Guo; Xinguo Sun; Wenliang Zhang; Ruichao Yue; Tianjiao Li; Alexandra Griffiths; Ali Reza Ahmadi; Zhaoli Sun; Zhenyuan Song; Zhanxiang Zhou
Journal:  Gut       Date:  2020-11-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.